“Hobbit” may bring a Hollywood ending to 2012 box office

LOS ANGELES (Reuters) – It took more than a decade, two directors and a lawsuit before “The Hobbit” made it to the big screen. Hollywood executives are crossing their fingers that the culmination of that journey will help smash movie box office records this year.

The film, which opens on December 14, is expected to contribute to the first annual box office increase in North America in three years, a sign that big movie studios have made more films enticing enough to get people into theaters and away from their TVs, games and the Internet.

“The Hobbit” follows this year’s other big box office successes “The Avengers,” which became the industry’s third-largest film with $ 623 million in U.S. sales, and “The Dark Knight Rises” and “The Hunger Games” which both passed $ 400 million.

Hollywood analysts predict the two months of the year that include “The Hobbit” and the finale of the “Twilight” vampire series may lift U.S. and Canadian ticket sales above the $ 10.6 billion record set in 2009.

“The fourth quarter is just gangbusters,” said box office watcher Phil Contrino, editor of the boxoffice.com website. “One movie after the other is exceeding expectations.”

Annual receipts are on track to end 5 percent above last year at $ 10.8 billion or more, projects Paul Dergarabedian, box office analyst for Hollywood.com. Ten films have already passed $ 200 million in ticket sales, compared to seven last year, when no film passed the $ 400 million mark.

That would be the first yearly box office increase in three years, and would be from a jump in admissions rather than a hike in ticket prices that traditionally fuel box office growth. Ticket prices are averaging $ 7.94, a penny increase from last year, according to the National Association of Theatre Owners.

Hollywood has raked in $ 9.7 billion so far in ticket sales and sold more than 1.2 billion tickets in the North American (U.S. and Canadian) market, 5.5 percent up on a year ago.

The industry thought it had a record in sight last year, only to see underwhelming performances from holiday releases such as thriller “The Girl with the Dragon Tattoo” and animated movie “Hugo,” which left ticket sales at a three-year low.

OFF THE COUCH

Studios face a difficult entertainment landscape in which consumers have an array of competing outlets for movie watching that includes DVR recordings, game players and movies streamed over computers and mobile phones.

Services like Netflix Inc have also made a dent in trips to the theater by offering cheap monthly rentals that make it easier to stay on the couch.

What has got people out of their homes, Hollywood moguls say, is a rise in the quality and variety of what is on screen.

This year, studios offered up a rush of big-budget blockbusters including “Skyfall,” the highest grossing of the 23 James Bond films that is still selling well with $ 227 million in domestic sales.

“Ted,” about a foul-mouthed stuffed bear, was a surprise winner with $ 219 million. Several mid-sized hits that won critical acclaim, including Steven Spielberg’s historical drama “Lincoln” and the Iran hostage thriller “Argo,” became box office darlings.

“There is something for everyone,” said Chris Aronson, president of domestic distribution at News Corp’s 20th Century Fox studio. “When we achieve that as an industry and the movies are of good quality, that’s when good things happen.”

Sony oiled up its Spider-Man franchise and collected $ 262 million by rebooting it with new stars Andrew Garfield and Emma Stone in “The Amazing Spider-Man.” Disney’s Pixar unit struck it big again with the animated movie “Brave.”

Hollywood did not escape some box office bombs. Two big-budget bets – board-game inspired thriller “Battleship” and outer space adventure “John Carter” – ranked among the most costly flops in movie history.

The mass killing at a Colorado movie theater in July marred the release of Batman film “The Dark Knight Rises.” But the film eventually grossed $ 448 million domestically, ranking as the year’s second-biggest.

Hollywood also overcame summer doldrums. The season that accounts for the bulk of yearly sales slumped 5 percent behind 2011. The second weekend in September produced the lowest-grossing weekend since 2001.

The pace quickened at the start of the holidays – the second-biggest movie going period – with “Twilight” finale “Breaking Dawn – Part 2″ and James Bond movie “Skyfall” leading record Thanksgiving sales of $ 291 million over five days.

“FOUR QUADRANT” FILM

That has got the industry’s hopes up for the Christmas season when families gather and shoppers fill malls. Comcast Corp’s Universal Pictures is releasing the musical adaptation “Les Miserables,” and The Weinstein Company offers up the Leonardo DiCaprio thriller “Django Unchained.” A street-brawling Tom Cruise returns in “Jack Reacher” from Viacom Inc’s Paramount Pictures.

But it is the dwarves and wizards from “The Hobbit: An Unexpected Journey,” that Hollywood is banking on to generate movie going mania. Set 60 years before the Oscar-winning “Lord of the Rings” trilogy, the movie is the kind that studios love – a “four quadrant” film that appeals to male, female, young and old, said Contrino of Boxoffice.com. He projects $ 137 million in opening weekend domestic sales, rising to $ 475 million through its theatrical run.

The film, based on the fantasy novel by J.R.R. Tolkien about the travels of hobbit Bilbo Baggins, almost did not make it to the screen at all. Director Peter Jackson made the “Lord of the Rings” trilogy when producers could not get “The Hobbit” rights that were held by MGM’s United Artists unit.

“The Hobbit“, also a trilogy, has been produced by MGM and Time Warner Inc but only after Jackson settled a lawsuit against Time Warner’s New Line Cinema unit in a dispute over profits from the “Rings” trilogy.

Now all the film has to do is delight fans with a new hobbit adventure across Middle Earth and deliver a record year for Hollywood.

(Reporting By Lisa Richwine. Editing by Jane Merriman)

Movies News Headlines – Yahoo! News

Read More..

Opinion: A Health Insurance Detective Story

I’VE had a long career as a business journalist, beginning at Forbes and including eight years as the editor of Money, a personal finance magazine. But I’ve never faced a more confounding reporting challenge than the one I’m engaged in now: What will I pay next year for the pill that controls my blood cancer?

After making more than 70 phone calls to 16 organizations over the past few weeks, I’m still not totally sure what I will owe for my Revlimid, a derivative of thalidomide that is keeping my multiple myeloma in check. The drug is extremely expensive — about $11,000 retail for a four-week supply, $132,000 a year, $524 a pill. Time Warner, my former employer, has covered me for years under its Supplementary Medicare Program, a plan for retirees that included a special Writers Guild benefit capping my out-of-pocket prescription costs at $1,000 a year. That out-of-pocket limit is scheduled to expire on Jan. 1. So what will my Revlimid cost me next year?

The answers I got ranged from $20 a month to $17,000 a year. One of the first people I phoned said that no matter what I heard, I wouldn’t know the cost until I filed a claim in January. Seventy phone calls later, that may still be the most reliable thing anyone has told me.

Like around 47 million other Medicare beneficiaries, I have until this Friday, Dec. 7, when open enrollment ends, to choose my 2013 Medicare coverage, either through traditional Medicare or a private insurer, as well as my drug coverage — or I will risk all sorts of complications and potential late penalties.

But if a seasoned personal-finance journalist can’t get a straight answer to a simple question, what chance do most people have of picking the right health insurance option?

A study published in the journal Health Affairs in October estimated that a mere 5.2 percent of Medicare Part D beneficiaries chose the cheapest coverage that met their needs. All in all, consumers appear to be wasting roughly $11 billion a year on their Part D coverage, partly, I think, because they don’t get reliable answers to straightforward questions.

Here’s a snapshot of my surreal experience:

NOV. 7 A packet from Time Warner informs me that the company’s new 2013 Retiree Health Care Plan has “no out-of-pocket limit on your expenses.” But Erin, the person who answers at the company’s Benefits Service Center, tells me that the new plan will have “no practical effect” on me. What about the $1,000-a-year cap on drug costs? Is that really being eliminated? “Yes,” she says, “there’s no limit on out-of-pocket expenses in 2013.” I tell her I think that could have a major effect on me.

Next I talk to David at CVS/Caremark, Time Warner’s new drug insurance provider. He thinks my out-of-pocket cost for Revlimid next year will be $6,900. He says, “I know I’m scaring you.”

I call back Erin at Time Warner. She mentions something about $10,000 and says she’ll get an estimate for me in two business days.

NOV. 8 I phone Medicare. Jay says that if I switch to Medicare’s Part D prescription coverage, with a new provider, Revlimid’s cost will drive me into Medicare’s “catastrophic coverage.” I’d pay $2,819 the first month, and 5 percent of the cost of the drug thereafter — $563 a month or maybe $561. Anyway, roughly $9,000 for the year. Jay says AARP’s Part D plan may be a good option.

NOV. 9 Erin at Time Warner tells me that the company’s policy bundles United Healthcare medical coverage with CVS/Caremark’s drug coverage. I can’t accept the medical plan and cherry-pick prescription coverage elsewhere. It’s take it or leave it. Then she puts CVS’s Michele on the line to get me a Revlimid quote. Michele says Time Warner hasn’t transferred my insurance information. She can’t give me a quote without it. Erin says she will not call me with an update. I’ll have to call her.

My oncologist’s assistant steers me to Celgene, Revlimid’s manufacturer. Jennifer in “patient support” says premium assistance grants can cut the cost of Revlimid to $20 or $30 a month. She says, “You’re going to be O.K.” If my income is low enough to qualify for assistance.

NOV. 12 I try CVS again. Christine says my insurance records still have not been transferred, but she thinks my Revlimid might cost $17,000 a year.

Adriana at Medicare warns me that AARP and other Part D providers will require “prior authorization” to cover my Revlimid, so it’s probably best to stick with Time Warner no matter what the cost.

But Brooke at AARP insists that I don’t need prior authorization for my Revlimid, and so does her supervisor Brian — until he spots a footnote. Then he assures me that it will be easy to get prior authorization. All I need is a doctor’s note. My out-of-pocket cost for 2013: roughly $7,000.

NOV. 13 Linda at CVS says her company still doesn’t have my file, but from what she can see about Time Warner’s insurance plans my cost will be $60 a month — $720 for the year.

CVS assigns my case to Rebecca. She says she’s “sure all will be fine.” Well, “pretty sure.” She’s excited. She’s been with the company only a few months. This will be her first quote.

NOV. 14 Giddens at Time Warner puts in an “emergency update request” to get my files transferred to CVS.

Frank Lalli is an editorial consultant on retirement issues and a former senior executive editor at Time Warner’s Time Inc.

Read More..

Jewel parent says sale talks proceeding

Exterior of Jewel-Osco's first "Green Store" located at 370 N. Desplaines in Chicago. (Antonio Perez / November 29, 2012)

By Emily Bryson York




Chicago Tribune reporter

6:51 a.m. CST, November 30, 2012

Supervalu, the Minneapolis-based parent of Jewel-Osco said sale talks are proceeding after stock closed down more than 18 percent Thursday, to $2.28.

The beleaguered grocery chain was likely moving to combat reports that sale talks with suitor Cerberus Capital Management had stalled over funding.

"The company continues to be in active discussion with several parties," according to the statement. "There can be no assurance that this process will result in any transaction or any change in the Company's overall structure or its business model."

Supervalu, the third-largest U.S. grocery chain, has acknowledged sale talks since the spring. The company has been closing stores and cutting jobs as it has underperformed competitors like Dominick's parent Safeway and Kroger.

If Supervalu does not sell to Cerberus, it may have to restructure on its own or sell off individual assets, which could have big tax consequences, Bloomberg said.

Reuters reported last month that buyout firm Cerberus was preparing a takeover bid for Supervalu, the third-largest U.S. supermarket chain.

Cerberus officials could not be reached immediately for comment.

-- Reuters contributed to this report

In addition to Jewel, Supervalu owns Albertsons, Cub and other regional grocery chains.

SVU data by YCharts

SVU data by YCharts

Read More..

Cutler fined $10K for flipping ball at Viking

Jay Cutler was fined $10,000 for taunting, according to a league source. He flipped the ball at Vikings cornerback A.J. Jefferson and was flagged late in the first quarter.

Culter joined the list of players fined following last Sunday’s Bears-Vikings game.

Eric Weems told the Tribune he was fined $7,875 for striking Jefferson late on the play immediately before Cutler taunted Jefferson.

Jefferson was flagged for unnecessary roughness on the play, but Weems wasn’t. Weems plans to appeal the fine.

"Heck yeah, I’m going to appeal it,’’ he said Friday. "I can’t just give it to them. I’ve got to appeal. They said I hit the guy late, which it was during the play.

"Of course I’m going to contest that once I get the video from them. I don’t see how I hit the guy late. And I didn’t get a penalty, either. So I don’t see how that works.’’

On Monday, Cutler addressed the flipping incident on WMVP-AM 1000. "I've got to be smarter than that," he said. "If anyone else on offense had done that I would have probably yelled at him like it can't happen here. I can't do it again obviously."

Besides Cutler and Weems, linebacker Brian Urlacher was fined $15,750 for a horse-collar tackle on Adrian Peterson while Henry Melton was fined $7,875 for grabbing Peterson’s facemask. Both players said they intend to appeal.

Vikings defensive end Jared Allen was fined $21,000 for his vicious hit on Bears right guard Lance Louis.  The end result was Louis tearing the anterior cruciate ligament in his left knee, ending his season.

vxmcclure@tribune.com

Twitter@vxmcclure23

Read More..

Korean pop rides “Gangnam Style” into U.S. music scene

LOS ANGELES (Reuters) – “Gangnam Style,” the catchy Korean song by rapper Psy, may have danced its way into the American charts but the Korean pop industry isn’t horsing around when it comes to capitalizing on the singer’s phenomenal U.S. success.

With “Gangnam Style” topping the current Billboard Digital Songs chart and becoming the most-watched video on YouTube ever with more than 800 million views, fellow Korean pop, or K-pop, artists are positioning themselves for similar U.S. breakthroughs.

Korea’s pop music industry is thriving. Over the past two years, a handful of K-pop acts including girl group 2NE1, boy band Super Junior and nine-piece band Girls Generation have embarked on mini-promotional tours around the United States to build their audience.

“Psy has opened doors and is shining a spotlight on K-pop. People are paying attention to what’s being done there,” Alina Moffat, general manager at YG Entertainment group, which manages Psy, told a recent entertainment industry conference in Los Angeles.

Psy’s vibrant music video, featuring his invisible pony-riding dance, also featured K-pop artists Kim Hyun-a of girl band 4Minute, and Deasung and Seungri of boy band Big Bang, all of whom are attempting to crack the U.S. market.

“YouTube has really changed the awareness of K-pop. Both American kids and second-generation Korean American kids are discovering it,” Kye Kyoungbon Koo, director of the Korea Creative Content Agency, told a panel at a Billboard and Hollywood Reporter conference in Los Angeles in October.

MARKETING THE NEXT BIG THING

For U.S. companies looking to invest, K-pop is being marketed as the next big thing, boasting young, stylish and influential artists who command devoted fan followings.

Moffat said car companies and mobile phone brands were among those being courted at KCON, a convention held in October in Irvine in Southern California that showcased K-pop artists.

“Kids are coming, they’re engaged, they want to spend money and sponsors saw that,” Moffat said.

Whether Psy or other K-pop artists can command a global following to rival Lady Gaga, Justin Bieber or Rihanna remains to be seen, but John Shim, senior producer at MTV World, believes it is the right genre to compete with pop music’s biggest names.

“K-pop admittedly is a very niche genre but I also think it’s the best equipped of Asian pop to cater to the U.S. audience,” Shim told Reuters.

Psy has helped to break down language barriers, keeping “Gangnam Style” in its original Korean form instead of adapting it to English when it became an international hit.

The singer told Reuters he was persuaded to keep it that way by his manager Scooter Braun, the talent scout responsible for Justin Bieber’s success, who signed Psy to his record label.

“I thought, ‘Should I translate this or not?’ because (the fans) have got to know what I’m talking about, and lyrics are a huge part,” Psy said.

CHATTING IN ENGLISH

But industry executives say at least one member of each K-Pop group is usually taught to be fluent in conversational English.

“The investment in language is costly, but effective,” said Ted Kim, president of South Korean music television channel Mnet. “It really matters that Psy can go on the Ellen DeGeneres TV show and have a conversation.”

Psy said he was proud his song succeeded in Korean, but he now wants to branch out into English.

“‘Gangnam Style’ is not the sort of thing that’s going to happen twice. I’ve definitely got to make something in English so I can communicate with my fans right now,” the singer said.

In Korea, bands such as SM Entertainment’s Super Junior and Girls Generation have became branding powerhouses, scoring endorsements ranging from cosmetics, fashion, video games, electronics and beverages.

In the United States, companies such as Samsung have already jumped on the K-pop train, sponsoring Korean boy band Big Bang’s U.S. tour.

But while the genre is gaining steam in the charts, it has yet to spill into ticket sales for tours, according to Gary Bongiovanni, editor in chief at Pollstar.com, which tracks concert sales.

“Psy may be able to sell out arenas in Asia, but not yet here. For the American audience, he has to prove that he’s more than a novelty act,” Bongiovanni said.

“K-pop has to prove itself before large companies spend money on it,” he added.

(Editing by Jill Serjeant and Eric Walsh)

Music News Headlines – Yahoo! News

Read More..

Hockey Coaches Defy Doctors on Concussions, Study Finds

Despite several years of intensive research, coverage and discussion about the dangers of concussions, the idea of playing through head injuries is so deeply rooted in hockey culture that two university teams kept concussed players on the ice even though they were taking part in a major concussion study.

The study, which was published Friday in a series of articles in the journal Neurosurgical Focus, was conducted during the 2011-12 hockey season by researchers from the University of Western Ontario, the University of Montreal, Harvard and other institutions.

“This culture is entrenched at all levels of hockey, from peewee to university,” said Dr. Paul S. Echlin, a concussion specialist and researcher in Burlington, Ontario, and the lead author of the study. “Concussion is a significant public health issue that requires a generational shift. As with smoking or seat belts, it doesn’t just happen overnight — it takes a massive effort and collective movement.”

The study is believed to be among the most comprehensive analyses of concussions in hockey, which has a rate of head trauma approaching that of football. Researchers followed two Canadian university teams — a men’s team and a women’s team — and scanned every player’s brain before and after the season. Players who sustained head injuries also received scans at three intervals after the injuries, with researchers using advanced magnetic resonance imaging techniques.

The teams were not named in the study, in which an independent specialist physician was present at each game and was empowered to pull any player off the ice for examination if a potential concussion was observed.

The men’s team, with 25 players and an average age of 22, played a 28-game regular season and a 3-game postseason. The women’s team, with 20 players and an average age of 20, played 24 regular-season games and no playoff games. Over the course of the season, there were five observed or self-reported concussions on the men’s team and six on the women’s team.

Researchers noted several instances of coaches, trainers and players avoiding examinations, ignoring medical advice or otherwise obstructing the study, even though the players had signed consent forms to participate and university ethics officials had given institutional consent.

“Unless something is broken, I want them out playing,” one coach said, according to the study.

In one incident, a neurologist observing the men’s team pulled a defenseman during the first period of a game after the player took two hits and was skating slowly. During the intermission the player reported dizziness and was advised to sit out, but the coach suggested he play the second period and “skate it off.” The defenseman stumbled through the rest of the game.

“At the end of the third period, I spoke with the player and the trainer and said that he should not play until he was formally evaluated and underwent the formal return-to-play protocol,” the neurologist said, as reported in the study. “I was dismayed to see that he played the next evening.”

After the team returned from its trip, the neurologist questioned the trainer about overruling his advice and placing the defenseman at risk.

“The trainer responded that he and the player did not understand the decision and that most of the team did not trust the neurologist,” according to the study. “He requested that the physician no longer be used to cover any more games.”

In another episode, a physician observer assessed a minor concussion in a female player and recommended that she miss the next night’s game. Even though the coach’s own playing career had ended because of concussions, she overrode the medical advice and inserted the player the next evening.

According to the report, the coach refused to speak to another physician observer on the second evening. The trainer was reluctant to press the issue with the coach because, the trainer said, the coach did not want the study to interfere with the team.

Read More..

Jewel parent says sale talks proceeding

Exterior of Jewel-Osco's first "Green Store" located at 370 N. Desplaines in Chicago. (Antonio Perez / November 29, 2012)

By Emily Bryson York




Chicago Tribune reporter

6:51 a.m. CST, November 30, 2012

Supervalu, the Minneapolis-based parent of Jewel-Osco said sale talks are proceeding after stock closed down more than 18 percent Thursday, to $2.28.

The beleaguered grocery chain was likely moving to combat reports that sale talks with suitor Cerberus Capital Management had stalled over funding.

"The company continues to be in active discussion with several parties," according to the statement. "There can be no assurance that this process will result in any transaction or any change in the Company's overall structure or its business model."

Supervalu, the third-largest U.S. grocery chain, has acknowledged sale talks since the spring. The company has been closing stores and cutting jobs as it has underperformed competitors like Dominick's parent Safeway and Kroger.

If Supervalu does not sell to Cerberus, it may have to restructure on its own or sell off individual assets, which could have big tax consequences, Bloomberg said.

Reuters reported last month that buyout firm Cerberus was preparing a takeover bid for Supervalu, the third-largest U.S. supermarket chain.

Cerberus officials could not be reached immediately for comment.

-- Reuters contributed to this report

In addition to Jewel, Supervalu owns Albertsons, Cub and other regional grocery chains.

SVU data by YCharts

SVU data by YCharts

Read More..

Wacker Drive to reopen Friday

The rebuilt north-south section of Wacker Drive will be completely open to traffic on Friday, including the lower-level roadway connection to Congress Parkway, Chicago transportation officials said Thursday.

The plan calls for the Wacker-Van Buren Street intersection to open between 8 and 9 a.m., according to the Chicago Department of Transportation.

Then, in early afternoon, Lower Wacker is scheduled to fully reopen in phases, for the first time since 2010, to allow for a controlled and orderly debut of the new underground ramp that is designed to provide drivers with a more gradual merge onto Congress Parkway, CDOT spokesman Pete ScalesÖ said.

Lower Wacker should be fully open in time for the evening rush, he said Thursday as crews were still finishing up lane striping and testing the new lighting.

The reopenings mark the completion, except for landscaping next spring and small punch list items, of the $300 millionÖ reconstruction of Wacker between Randolph StreetÖ and Congress.Ö

The stretch, which features wider sidewalks and crosswalks, is used by 150,000Ö pedestrians on an average weekday, CDOT said. It also serves about 60,000Ö vehicles, half on Upper Wacker and half on Lower Wacker. The average daily traffic count on Congress is 75,700Ö vehicles.

“Recreating a double-deck highway boulevard through the downtown was no small task,’’ said Chicago Transportation Commissioner Gabe Klein.Ö “Now it’s a modern, much more safe and efficient roadway whether you are in a car, using transit, biking or walking.’’

jhilkevitch@tribune.com

Twitter @jhilkevitch

Read More..

“Homeland” in, “Boardwalk Empire” out in PGA TV nominations

LOS ANGELES (Reuters) – Emmy-winning dramas “Homeland”, “Mad Men” and British period piece “Downton Abbey” will compete for the annual Producers Guild Awards for the top shows on U.S. television, organizers announced on Wednesday.

But last year’s winner – HBO’s lavish Prohibition-era gangster drama “Boardwalk Empire” – failed to make the cut this year with the Producers Guild of America, one of the leading professional guilds in Hollywood.

Instead, the producers of popular fantasy drama “Game of Thrones” and drug underworld show “Breaking Bad” round out the nominees for the top PGA prize in television.

The PGA also nominated the producers of comedies “Modern Family”, “The Big Bang Theory”, “Louie”, “30 Rock” and Larry David’s wry “Curb Your Enthusiasm” as contenders for its 2013 awards on the small screen.

In the reality genre, singing contest “The Voice” will go head to head with fashion show “Project Runway”, “Top Chef”, “Dancing with the Stars” and Emmy darling “The Amazing Race”.

Hollywood‘s guilds represent professionals in their respective industries, and recognition by peers can go a long way toward boosting a producer’s career.

The PGA will announce nominees in its closely watched movie category in early January, and hand out its awards for film and television at a ceremony in Hollywood on January 26.

(Reporting by Jill Serjeant; Editing by Dale Hudson)

TV News Headlines – Yahoo! News

Read More..

Clearing the Fog Around Personality Disorders

For years they have lived as orphans and outliers, a colony of misfit characters on their own island: the bizarre one and the needy one, the untrusting and the crooked, the grandiose and the cowardly.

Their customs and rituals are as captivating as any tribe’s, and at least as mystifying. Every mental anthropologist who has visited their world seems to walk away with a different story, a new model to explain those strange behaviors.

This weekend the Board of Trustees of the American Psychiatric Association will vote on whether to adopt a new diagnostic system for some of the most serious, and striking, syndromes in medicine: personality disorders.

Personality disorders occupy a troublesome niche in psychiatry. The 10 recognized syndromes are fairly well represented on the self-help shelves of bookstores and include such well-known types as narcissistic personality disorder, avoidant personality disorder, as well as dependent and histrionic personalities.

But when full-blown, the disorders are difficult to characterize and treat, and doctors seldom do careful evaluations, missing or downplaying behavior patterns that underlie problems like depression and anxiety in millions of people.

The new proposal — part of the psychiatric association’s effort of many years to update its influential diagnostic manual — is intended to clarify these diagnoses and better integrate them into clinical practice, to extend and improve treatment. But the effort has run into so much opposition that it will probably be relegated to the back of the manual, if it’s allowed in at all.

Dr. David J. Kupfer, a professor of psychiatry at the University of Pittsburgh and chairman of the task force updating the manual, would not speculate on which way the vote might go: “All I can say is that personality disorders were one of the first things we tackled, but that doesn’t make it the easiest.”

The entire exercise has forced psychiatrists to confront one of the field’s most elementary, yet still unresolved, questions: What, exactly, is a personality problem?

Habits of Thought

It wasn’t supposed to be this difficult.

Personality problems aren’t exactly new or hidden. They play out in Greek mythology, from Narcissus to the sadistic Ares. They percolate through biblical stories of madmen, compulsives and charismatics. They are writ large across the 20th century, with its rogues’ gallery of vainglorious, murderous dictators.

Yet it turns out that producing precise, lasting definitions of extreme behavior patterns is exhausting work. It took more than a decade of observing patients before the German psychiatrist Emil Kraepelin could draw a clear line between psychotic disorders, like schizophrenia, and mood problems, like depression or bipolar disorder.

Likewise, Freud spent years formulating his theories on the origins of neurotic syndromes. And Freudian analysts were largely the ones who, in the early decades of the last century, described people with the sort of “confounded identities” that are now considered personality disorders.

Their problems were not periodic symptoms, like moodiness or panic attacks, but issues rooted in longstanding habits of thought and feeling — in who they were.

“These therapists saw people coming into treatment who looked well put-together on the surface but on the couch became very disorganized, very impaired,” said Mark F. Lenzenweger, a professor of psychology at the State University of New York at Binghamton. “They had problems that were neither psychotic nor neurotic. They represented something else altogether.”

Several prototypes soon began to emerge. “A pedantic sense of order is typical of the compulsive character,” wrote the Freudian analyst Wilhelm Reich in his 1933 book, “Character Analysis,” a groundbreaking text. “In both big and small things, he lives his life according to a preconceived, irrevocable pattern.”

Others coalesced too, most recognizable as extreme forms of everyday types: the narcissist, with his fragile, grandiose self-approval; the dependent, with her smothering clinginess; the histrionic, always in the thick of some drama, desperate to be the center of attention.

In the late 1970s, Ted Millon, scientific director of the Institute for Advanced Studies in Personology and Psychopathology, pulled together the bulk of the work on personality disorders, most of it descriptive, and turned it into a set of 10 standardized types for the American Psychiatric Association’s third diagnostic manual. Published in 1980, it is a best seller among mental health workers worldwide.

These diagnostic criteria held up well for years and led to improved treatments for some people, like those with borderline personality disorder. Borderline is characterized by an extreme neediness and urges to harm oneself, often including thoughts of suicide. Many who seek help for depression also turn out to have borderline patterns, making their mood problems resistant to the usual therapies, like antidepressant drugs.

Today there are several approaches that can relieve borderline symptoms and one that, in numerous studies, has reduced hospitalizations and helped aid recovery: dialectical behavior therapy.

This progress notwithstanding, many in the field began to argue that the diagnostic catalog needed a rewrite. For one thing, some of the categories overlapped, and troubled people often got two or more personality diagnoses. “Personality Disorder-Not Otherwise Specified,” a catchall label meaning little more than “this person has problems” became the most common of the diagnoses.

It’s a murky area, and in recent years many therapists didn’t have the time or training to evaluate personality on top of everything else. The assessment interviews can last hours, and treatments for most of the disorders involve longer-term, specialized talk therapy.

Psychiatry was failing the sort of patients that no other field could possibly help, many experts said.

“The diagnoses simply weren’t being used very much, and there was a real need to make the whole system much more accessible,” Dr. Lenzenweger said.

Resisting Simplification 

It was easier said than done.

The most central, memorable, and knowable element of any person — personality — still defies any consensus.

A team of experts appointed by the psychiatric association has worked for more than five years to find some unifying system of diagnosis for personality problems.

The panel proposed a system based in part on a failure to “develop a coherent sense of self or identity.” Not good enough, some psychiatric theorists said.

Later, the experts tied elements of the disorders to distortions in basic traits.

This article has been revised to reflect the following correction:

Correction: November 29, 2012

An earlier version of this article misstated the number of traits included in the proposed criteria for narcissistic personality disorder.   The final proposal relies on two personality traits, not four.

Read More..